Artelo Biosciences (ARTL) Institutional Ownership

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Free ARTL Stock Alerts

$1.32

-0.14 (-9.62%)

(As of 04/17/2024 ET)

Compare

Current Institutional Ownership Percentage: 0.87%
Number of Institutional Buyers (last 12 months): 0

Number of Institutional Sellers (last 12 months): 1
Total Institutional Outflows (last 12 months): $20.18K

Get ARTL Insider Trade Alerts

Want to know when executives and insiders are buying or selling Artelo Biosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

ARTL Institutional Buying and Selling by Quarter

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

Artelo Biosciences Major Shareholders & Ownership History

Export to Excel

Reporting Date	Major Shareholder Name	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/15/2023	Two Sigma Advisers LP	27,262	$63K	0.0%	-24.2%	0.955%
11/15/2022	Two Sigma Advisers LP	35,062	$121K	0.0%	N/A	1.228%
11/15/2022	Two Sigma Investments LP	10,608	$37K	0.0%	N/A	0.371%
11/15/2022	Vanguard Group Inc.	71,038	$245K	0.0%	-89.6%	2.487%
5/13/2022	Renaissance Technologies LLC	182,619	$82K	0.0%	+67.8%	0.432%
5/13/2022	Vanguard Group Inc.	683,896	$308K	0.0%	-23.2%	1.617%
9/17/2021	Virtu Financial LLC	22,594	$27K	0.0%	-85.3%	0.092%
8/13/2021	Renaissance Technologies LLC	556,738	$663K	0.0%	N/A	2.273%
8/13/2021	Vanguard Group Inc.	862,172	$1.03M	0.0%	+247.5%	3.520%
8/12/2021	Penserra Capital Management LLC	28,427	$27K	0.0%	N/A	0.116%
8/11/2021	Bank of New York Mellon Corp	86,603	$103K	0.0%	-15.4%	0.354%
8/6/2021	HighTower Advisors LLC	62,000	$74K	0.0%	N/A	0.253%
5/19/2021	Virtu Financial LLC	153,769	$251K	0.0%	N/A	0.664%
5/18/2021	Citadel Advisors LLC	180,814	$295K	0.0%	N/A	0.781%
5/18/2021	Jane Street Group LLC	21,108	$34K	0.0%	N/A	0.091%
5/13/2021	Kepos Capital LP	200,000	$326K	0.0%	-20.0%	0.864%
5/13/2021	Bank of New York Mellon Corp	102,390	$167K	0.0%	N/A	0.442%
5/12/2021	Geode Capital Management LLC	141,273	$230K	0.0%	+132.1%	0.610%
5/12/2021	UBS Group AG	15,675	$26K	0.0%	N/A	0.068%
4/6/2021	LVM Capital Management Ltd. MI	20,000	$33K	0.0%	N/A	0.127%

(Data available from 1/1/2016 forward)

ARTL Institutional Ownership - Frequently Asked Questions

Who are the largest shareholders of ARTL shares?: During the previous two years, the following institutional investors and hedge funds held shares of Artelo Biosciences shares: Vanguard Group Inc. ($245K), Renaissance Technologies LLC ($82K), and Two Sigma Advisers LP ($63K), Two Sigma Investments LP ($37K).Learn more on ARTL's institutional investors.
What percentage of Artelo Biosciences stock is owned by institutional investors?: 0.87% of Artelo Biosciences stock is owned by institutional investors. Learn more on ARTL's institutional investor holdings.
Which institutional investors have been buying Artelo Biosciences stock?: The following institutional investors have purchased Artelo Biosciences stock in the last 24 months: Renaissance Technologies LLC ($73.82K), Two Sigma Advisers LP ($35.06K), and Two Sigma Investments LP ($10.61K).

How much institutional buying is happening at Artelo Biosciences?: Institutional investors have bought a total of 119,489 shares in the last 24 months. This purchase volume represents approximately $655.84K in transactions.
Which Artelo Biosciences major shareholders have been selling company stock?: The following institutional investors have sold Artelo Biosciences stock in the last 24 months: Vanguard Group Inc. ($819.89K), and Two Sigma Advisers LP ($8.70K).
How much institutional selling is happening at Artelo Biosciences?: Institutional investors have sold a total of 828,585 shares in the last 24 months. This volume of shares sold represents approximately $3.53M in transactions.

Related Companies:

This page (NASDAQ:ARTL) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Artelo Biosciences (ARTL) Institutional Ownership

ARTL Institutional Buying and Selling by Quarter

Artelo Biosciences Major Shareholders & Ownership History

ARTL Institutional Ownership - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Artelo Biosciences (ARTL) Institutional Ownership

Institutional Ownership Changes (13F Filings) for Artelo Biosciences (NASDAQ:ARTL)

ARTL Institutional Buying and Selling by Quarter

Artelo Biosciences Major Shareholders & Ownership History

ARTL Institutional Ownership - Frequently Asked Questions